Article
Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C.
Antiviral therapy - 1 Jan 2005
Liu Chun-Jen, Jeng Yung-Ming, Chen Pei-Jer, Lai Ming-Yang, Yang Hung-Chih, Huang Wen-Ling, Kao Jia-Horng, Chen Ding-Shinn
Abstract excerpt
BACKGROUND/AIMS: The prevalence and clinical implications of non-alcoholic fatty liver disease in patients with chronic hepatitis C remain unknown in Taiwan. METHODS: We addressed the relevant issues by analysing 95 naive Taiwanese patients infected with either hepatitis C virus (HCV) genotype 1 (n = 57) or 2 (n = 38), receiving interferon alone (n = 41) or in combination with ribavirin (n=54) therapy. A single...
Topics
Join the communities discussing this publication.